XAIR · Beyond Air, Inc.
$5.50
+0.04 (+0.73%)
At close · Jul 29
Going-concern doubt
— flagged Jun 26, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-K filed Jun 26, 2026
Market Cap
$78.68M
Shares
14.41M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.46
Open$5.41
Day$5.41–5.59
52W$0.33–9.60
Avg vol 30d168K
Short int21K · 0.1% float · 1.0d
Short vol64%
Last earningsJun 26, 2026
DataJan 2020–Jul 2026
Filing10-K · Jun 26
Up next
Next earnings call
Sep 24, 2026
Est · unconfirmed
· in 8 wks
FQ2-27 quarter ends
~Sep 30, 2026
Est
filed Jun 26, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+254%
above
Price vs 50-day avg
+106%
above
RSI (14)
57
neutral
MACD trend
Negative
52-week position
55%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+1044%
trailing
6-month return
+359%
trailing
YTD return
+652%
this year
Relative strength
+351%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $2 — 50d above 200d
Institutional flow
Distributing
5 of 29 funds reported for Jun 30 · net -1 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.15% of float · ▼ -93.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
29 holders — near 1-yr high, broad support
Squeeze score
41
elevated · 0–100
Fundamentals
Revenue growth
+107%
Y/Y
Gross margin
3%
expanding
EPS growth
+71%
Y/Y
Free cash flow
$-19.2M
Balance sheet
$10.8M
net debt
Quant / Vol
risk profile
Volatility
2006%
annualized · 1-yr
Max drawdown
−90%
past year
ATR
11.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jun 26, 2026
year ending December 31, 2026
Revenue
Maintained
$8M
prior FY $7.68M
midpoint +4.2% Y/Y
year ending December 31, 2027
Revenue
Initiated
$16M – $18M
prior FY $7.68M
midpoint +121.4% Y/Y
Guided vs delivered
· last 1 settled
Revenue
calendar year 2026
guided $8M
$7.68M
Miss −4.0%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+254%
Bullish
Price vs 50-day avg
+106%
Bullish
RSI (14)
57
Neutral
MACD trend
Negative
Bearish
52-week position
55%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $3 › 200d $2 — 50d above 200d
Institutional flow
Distributing
5 of 29 funds reported for Jun 30 · net -1 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.15% of float · ▼ -93.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
29 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $0
Now $5 · 55%
52-wk high $10
vs 200-day avg +254%
vs 50-day avg +106%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Net cash burn, excluding inflows from financing activities | $19.1M | fiscal year ended March 31, 2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
XAIR
this stock
Beyond Air, Inc.
|
$78.68M | +652.1% | +107.3% | — | 0.1% |
|
ABT
Abbott Laboratories
|
$186.84B | -13.9% | +5.7% | 30.1 | 1.4% |
|
SYK
Stryker Corp
|
$132.87B | -1.1% | +11.2% | 40.1 | 1.8% |
|
MDT
Medtronic plc
|
$111.21B | -8.8% | +8.4% | 23.3 | 1.5% |
|
BSX
Boston Scientific Corp
|
$68.43B | -51.7% | +5.5% | 19.3 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XAIR | -8.7% | +1043.9% | +358.8% | +1124.5% | +652.1% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | -7.7% | +1044.0% | +351.4% | +1125.3% | +643.4% |